NANOG and familial pancreatic carcinoma: In 2016, Liu et al. found that the lncRNA uc.345 was able to increase the number of CD44+/CD24+ cells and Oct4, Sox2, Nanog and CD133 levels in pancreatic cancer cells by regulating the levels of hnRNPL, an important splicing factor [111].